Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $6.8200 (-3.81%) ($6.8200 - $6.8200) on Fri. Sep. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.03% (three month average) | RSI | 78 | Latest Price | $6.8200(-3.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -1.5% a day on average for past five trading days. | Weekly Trend | AUTL advances 5.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(53%) ARKG(49%) ARKK(48%) IBUY(48%) IWO(48%) | Factors Impacting AUTL price | AUTL will decline at least -2.015% in a week (0% probabilities). VIXM(-33%) VXX(-29%) SHY(-20%) TLT(-17%) BNDX(-15%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.015% (StdDev 4.03%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.1(-3.94%) | 10 Day Moving Average | $7.06(-3.4%) | 20 Day Moving Average | $6.55(4.12%) | To recent high | -14.1% | To recent low | 28.3% | Market Cap | $356m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |